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Abstract
Cardioprotective efficacy of remote ischemic preconditioning (RIPC) remains
controversial. Experimental studies investigating RIPC have largely monitored
cardiovascular changes during index ischemia and reperfusion with little work
investigating changes during RIPC application. This work aims to identify car-
diovascular changes associated with autonomic nervous system (ANS) activity
during RIPC and prior to index ischemia. RIPC was induced in anesthetized
male C57/Bl6 mice by four cycles of 5 min of hindlimb ischemia using
inflated cuff (200 mmHg) followed by 5 min reperfusion. Electrocardiography
(ECG) and microcirculatory blood flow in both hindlimbs were recorded
throughout RIPC protocol. Heart rate variability (HRV) analysis was per-
formed using ECG data. Hearts extracted at the end of RIPC protocol were
used either for measurement of myocardial metabolites using high-perfor-
mance liquid chromatography or for Langendorff perfusion to monitor func-
tion and injury during 30 min index ischemia and 2 h reperfusion. Isolated-
perfused hearts from RIPC animals had significantly less infarct size after
index ischemia and reperfusion (34  5% vs. 59  7%; mean  SE
P < 0.05). RIPC protocol was associated with increased heart rate measured
both in ex vivo and in vivo. Frequency ratio of HRV spectra was altered in
RIPC compared to control. RIPC was associated with a standard hyperemic
response in the cuffed-limb but there was a sustained reduction in blood flow
in the uncuffed contralateral limb. RIPC hearts (prior to index ischemia) had
significantly lower phosphorylation potential and energy charge compared to
the control group. In conclusion, RIPC is associated with changes in ANS
activity (heart rate, blood flow, HRV) and mild myocardial ischemic stress
that would contribute to cardioprotection.
Introduction
Remote ischemic preconditioning (RIPC) is a phe-
nomenon where preconditioning a tissue distant to the
heart confers cardioprotection against index ischemia and
reperfusion. It is suggested that the signal from the dis-
tant tissue is transmitted to the heart via neural or
humoral signaling pathways or an overlap between both
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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(Gho et al. 1996; Gill et al. 2015; Heusch et al. 2015).
However, the role of either pathway or the exact mecha-
nism(s) involved is not presently known.
The neural hypothesis proposes that substances (e.g.,
autacoids, adenosine, and bradykinin) released locally in
the remotely ischemic area activate a neural afferent
pathway which in turn activates various efferent path-
ways in the heart that induce cardioprotection (Tang
et al. 1999; Schoemaker and van Heijningen 2000; Xiao
et al. 2001; Brzozowski et al. 2004a; Dong et al. 2004;
Donato et al. 2013). The efferent pathway appears to
involve the autonomous nervous system (ANS). Evidence
for the involvement of the ANS comes from work show-
ing pretreatment with the ganglionic blocker hexametho-
nium, inhibits RIPC cardioprotection (Gho et al. 1996).
Additionally, the cardioprotective effect of RIPC disap-
pears in animals subjected to nerve resection, vagotomy
(Mastitskaya et al. 2016), blockade of muscarinic cholin-
ergic receptors (Ding et al. 2001; Brzozowski et al.
2004b; Dong et al. 2004; Lim et al. 2010; Donato et al.
2013), or silencing vagal preganglionic neurons in the
brainstem (Mastitskaya et al. 2012). Recent evidence sug-
gests that cardioprotection is partially mediated by
intrinsic cardiac ganglia in response to increased systemic
efferent vagal tone (Pickard et al. 2016). Moreover, there
is also evidence supporting a role for sympathetic adren-
ergic stimulation in RIPC-induced cardioprotection
(Taliyan et al. 2010). Involvement of ANS in RIPC-
induced effects also includes changes in organ blood flow
and cardiac output. For example, RIPC application in
anesthetized pigs was associated with coronary vasodila-
tion in paced hearts (Shimizu et al. 2007). RIPC in con-
scious volunteers also induces vasodilatation of the
contralateral artery (right brachial artery) and improved
parasympathetic activity as measured using heart rate
variability (HRV) (Enko et al. 2011). However, a recent
study could only detect HRV changes in patients with
coronary disease but not in healthy volunteers (Zagidul-
lin et al. 2016). Moreover, RIPC in healthy volunteers
attenuated I/R sympathetic activation following ischemia/
reperfusion limb injury (Lambert et al. 2016). It is evi-
dent therefore that the effect of RIPC application on the
ANS activity remains controversial. Furthermore, it is
anticipated that changes in sympathetic activity would
alter cardiac metabolic demand. Direct evidence to sup-
port this view is currently lacking as most studies have
largely reported changes in signaling pathways after
reperfusion (Wolfrum et al. 2002; Yamamura et al. 2005;
Serejo et al. 2007; Tamareille et al. 2011). Therefore, the
aim of this work was to address these issues and directly
link them to cardioprotection using anesthetized mouse
model. In particular, we investigated the effect of RIPC
on key cardiovascular activities associated with ANS
including blood flow, HR, HRV, and myocardial energet-
ics prior to index ischemia.
Materials and Methods
Animals and ethics statement
Male C57/BL6 wild-type mice (25–28 weeks old, 26–
33 g, n = 60) were used for all experiments. All animals
were purchased from B&K Universal. Animals were kept
at the University of Bristol Veterinary School until used.
Animal work was performed in accordance with the UK
Animals (Scientific Procedures) Act of 1986 and
approved by the University of Bristol Animal Welfare
and Ethical Review Board (Permit numbers: PPL 30/2859
and PIL 30/9564).
RIPC protocol
Mice were anesthetized by an intraperitoneal injection
(0.020 mL/g weight) of 2.5% tribromoethanol (Avertin)
(Sigma-Aldrich, Gillingham, Dorset, U.K.), allowed
~5 min to become fully anesthetized (evidenced by lack
of response to toe or tail pinch). A specially designed
small (1.6 9 9 cm) pressure cuff (Hokanson, Inc.,
Bellevue, WA, USA) was placed around the hind limb at
the inguinal level (Fig. 1A) and RIPC was induced by
four cycles of 5 min of limb ischemia at 200 mmHg fol-
lowed by 5 min of reperfusion. The applied pressure was
selected as it was used earlier (Li et al. 2011) and was
associated with complete block of microcirculatory blood
flow (Fig. 1B) followed by significant hyperemia
(Fig. 1C). Control group had a deflated cuff placed on
the lower limb. Body temperature was maintained at
around 37°C using a heating pad.
Langendorff-perfused heart
At the end of 50 min anesthesia involving control or
RIPC protocols, animals were killed by cervical disloca-
tion. Hearts were rapidly excised and placed in cold
Krebs–Henseleit (K-H) buffer. The excess tissue was
removed from the heart, and the aorta was cannulated
with a metal cannula via modified Langendorff perfusion
apparatus and perfused under constant pressure of
60 mmHg with 37°C K-H solution containing (mmol/L)
NaCl 120, KCl 4.8, CaCl2 2, MgSO4 1.2, KH2PO4 1.2,
NaHCO3 25, and glucose 11. The solution was filtered
and continuously gassed with 95% O2, 5% CO2 (pH
7.4). The perfusion chamber was tightly closed and tem-
perature controlled to ensure the heart was maintained at
constant temperature (~37°C) throughout. Cardiac con-
tractile function was measured with a force-transducer
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(MLT0402 [2 g]; AD Instruments, Castle Hill, Australia)
connected to the apex of the heart using a metal hook.
Hearts were preloaded with a resting tension of 250 mg.
Perfused hearts were left to stabilize for ~30 min fol-
lowed by 30 min global ischemia (introduced by switch-
ing off the pump) and 2 h reperfusion. Developed
tension was monitored using Mac Lab data acquisition
system (AD Instruments) and was used to compute heart
rate. Cardiac pump function was expressed as rate ten-
sion product (RTP), the product of heart rate and devel-
oped tension. Developed tension and subsequently heart
rate could not be computed in the reperfused injured
(hyper-contracted) heart. Therefore only the following
parameters were measured: time to stop beating, time to
rigor, changes in diastolic tension and flow rate. Diastolic
tension was used as a marker of functional impairment
during reperfusion.
Measurement of infarct size
At the end of reperfusion hearts were perfused in Langen-
dorff mode with 1% (W/V) Triphenyltetrazolium chloride
in phosphate buffer saline for 8 min at a flow rate of
2.5 mL/min. After staining, the heart was removed,
wrapped in Clingfilm and stored in freezer for 1 h. The
frozen heart was cut transversely into four (~2-mm-thick)
slices from apex to the top of the ventricles and left over-
night in 10% formaldehyde for fixation. The viable myo-
cardium stained red, and infarct tissues appeared pale
white. Later each side of the slices was scanned by
Figure 1. Monitoring microcirculatory blood flow using laser Doppler flowmetry. This figure shows a photo of a mouse with a cuff placed
around the hind limb and an image showing both the color intensity scale and intensity in the limbs reflecting blood flow (A). The lower panels
show cessation of blood flow during ischemia (200 mmHg cuff inflation) and hyperemia during reperfusion following cuff deflation (B and C).
(D) A schematic of the experimental protocols. In summary, mice were anesthetized for 50 min and divided into control and RIPC groups. In
the RIPC group, the animals were exposed to four cycles of 5 min limb ischemia followed by 5 min reperfusion. Blood flow in both limbs or
ECG was monitored during this period. At the end of RIPC/control protocol, hearts were extracted and used for either metabolite extraction or
for Langendorff perfusion. RIPC, remote ischemic preconditioning; ECG, electrocardiography.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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electronic scanner (Epson perfection 4990 photo). The
infarct size was determined by computerized planimetry
using AlphaEaseFC software (Alpha Innotech, San Lean-
dro, CA, USA). Since the entire heart was at risk from
global ischemia, the ratio of necrotic areas to total slice
areas of the four myocardial slices were used to estimate
percentage of necrosis.
Measurement of creatine kinase
In all Langendorff experiments involving index ischemia
and reperfusion, coronary effluent was collected at regular
intervals. Collections were made preischemia, and at 1, 3, 5,
10, 20, 30, 60, 90, and 120 min during reperfusion. Crea-
tine kinase (CK-MB) activity in these samples was deter-
mined using a commercially available kit (Randox,
Crumlin, County Antrim, U.K.) and measured using a
spectrophotometer at 340 nm, 37°C and expressed as U/L.
Laser Doppler flowmetry
Blood flow in the hind limb was monitored throughout
the RIPC protocol using laser Doppler flowmetry
(moorLDI2 imager Perimed, Sweden, and Moor, USA). A
color-coded image representing the microvascular blood
flow distribution after each RIPC cycle (after and during
5 min occlusion) for the whole procedure (50 min) was
captured on the monitor (see Results below). Color inten-
sity scheme (Fig. 1A) is used to quantify blood flow in
the tissue.
Electrocardiography (ECG) in vivo
Approximately 5 min after anesthetic induction, three nee-
dle (29G) electrodes (MLA1204; AD Instruments) were
inserted subcutaneously into the right pelvic limb area and
into each thoracic limb area of 32 mice (n = 19 for control
and 13 for RIPC). The ECG signal was recorded and ana-
lyzed using Bio amplifier connected to the data acquisition
system (Power Lab/8SP; AD Instruments). The data were
recorded continuously for the whole RIPC procedure
(50 min). Heart rate was estimated using R-R interval of
the least noisy traces of the ECG.
HRV analysis
HRV is widely used as a measure of ANS activity to the
heart (sympatho-vagal balance) (Roy and Ghatak 2013)
and can help to elucidate the role and the contribution of
the ANS in RIPC. The HRV and HR analysis was per-
formed using randomly selected ECG recordings from 12
mice (6/group) that had least noisy traces and sufficient
signal to enable HRV analysis. The following ranges of
the analyzed HRV spectrum were selected for the fre-
quency quantification (Fleishman et al. 2014): low fre-
quency (LF, 0.08–0.12 Hz) and high frequency (HF, 0.15–
0.35 Hz). The HF reflects peripheral activity of parasym-
pathetic system while LF predominantly corresponds to
the activity of peripheral sympathetic modulations (Task
Force of the European Society of Cardiology the North
American Society of Pacing Electrophysiology, 1996).
Additionally, the ratio (HF/LF) has been used to assess
changes in vagus activity relative to the activity of sympa-
thetic system.
Measurement of cellular metabolites
Cardiac metabolites from hearts collected after 50 min of
anesthesia with or without RIPC were extracted and mea-
sured using high-performance liquid chromatography
(HPLC) as described previously (Imura et al. 2001; Modi
et al. 2004) and based on earlier work (Ally and Park
1992). In brief, frozen myocardial tissue samples were
crushed in liquid nitrogen and a small amount added to
tube containing 500 lL of 4.8% perchloric acid, vortexed,
weighed (to obtain sample wet weight) and then spun at
4500 rpm for 15 min at 4°C. The supernatant was neu-
tralized with equal volume of 0.44 mol/L K2CO3, vortexed
and then spun at 4500 rpm for 15 min at 4°C. The super-
natant was taken and stored at 20°C until analyzed for
cellular metabolites using an HPLC Beckman System and
a 3-lm octadecyl silane Hypersil column (150 9 4.6 mm)
(Thermo Scientific, Newport, U.K.). Eluent A contained
150 mmol/L KH2PO4 and 150 mmol/L KCl, set at pH 6.0
with KOH. Eluent B consisted of eluent A with 15% (v/v)
HPLC grade acetonitrile. A low-pressure gradient mixing
device was used to control the composition of the mobile
phase. The amount of eluent B changed linearly between
the time points. The analytical column was maintained at
a constant temperature in the range 17–19°C and absorp-
tion was measured at 254 nm. The metabolites measured
were ATP, ADP, AMP, GTP, GDP, GMP, IMP, xanthine,
hypoxanthine, Nicotinamide adenine dinucleotide
(NAD+), inosine, and adenosine. The area under the peak
for each metabolite was determined and compared to the
standard sample, then corrected for weight.
Statistical analysis
Statistical analyses were performed using Statveiw for
Windows (SAS Institute Inc., Cary, NC, USA) and Prism
5 Version 5.01 software (GraphPad, La Jolla, CA, USA).
Data were expressed as the mean  SEM. Differences
between control and RIPC groups were analyzed using
unpaired t-test P < 0.05 considered significant, whereas
differences within the same group were analyzed using
2017 | Vol. 5 | Iss. 3 | e13085
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paired t-test. Data were tested for normal distribution
using Kolmogorov–Smirnov test and equal variance using
the F-test. Area under the curve to estimate total creatine
kinase release was calculated using Trapezium rule on
Excel spread sheet. Repeated measures analysis of variance
(ANOVA) was used for changes overtime and significance
tested using Bonferroni-Dunn post hoc test.
Results
The effect of RIPC on cardiac injury
following index ischemia and reperfusion
Myocardial injury following index ischemia and reperfu-
sion was determined by measuring release of cardiac
enzyme creatine kinase and the infarcted area in control
and RIPC hearts (Fig. 2A and B). RIPC induced signifi-
cant (P < 0.05) reduction in the percentage of infarct size
compared to control (34  5% vs. 59  7%). RIPC also
significantly reduced total release of creatine kinase
compared to control (13,000  1000 IU/mg vs.
21,000  2000 IU/mg dry tissue). Furthermore, RIPC
was associated with significantly better recovery in dias-
tolic tension measured at different time points during
reperfusion compared to control (Fig. 2C). Table 1 shows
no effects on parameters during index ischemia (e.g., time
to stop beating, time to rigor, changes in diastolic ten-
sion).
Cardiovascular effects of RIPC prior to index
ischemia
Effect of RIPC on heart rate in vitro and in vivo
Figure 3A shows the data for computed heart rate and
heart RTP measured after 30 min of Langendorff
Figure 2. Cardiac ischemia and reperfusion injury in Langendorff heart. The Effects of RIPC on infarct size and creatine kinase release.
Langendorff-perfused hearts with or without RIPC application were exposed to 30 min ischemia followed by 120 min reperfusion. (A) Infarct
size measured using TTC and expressed as percentage of risk area. Inset shows representative sections from control and RIPC hearts with
darker parts indicating viable tissue. (B) Creatine kinase activity from hearts effluents collected preischemia and during reperfusion. (C) The
effects of RIPC on diastolic tension measured at 20, 30, 60, 90, and 120 min during reperfusion. Data are presented as mean  SEM (n = 6–
10 hearts/group for different endpoints). *P < 0.05 versus corresponding control (or basal) using either unpaired t-test (A and B) or repeated
measures ANOVA with Bonferroni-Dunn test (C). RIPC, remote ischemic preconditioning; TTC, triphenyltetrazolium chloride; ANOVA, analysis of
variance.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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perfusion (prior to index ischemia). Perfused hearts from
animals treated with RIPC had a significantly higher heart
rate and RTP compared to control hearts.
Following the induction of anesthesia, heart rate drops
to levels of around 450 BPM and slowly recovers to
higher levels but remains relatively lower than physiologi-
cal levels of 550–600 (data not shown). The extent of this
increase tended to be higher in RIPC compared to con-
trol. The percentage change in heart rate from baseline
was calculated for each mouse in vivo. There was a grad-
ual and similar increase in heart rate for both control and
RIPC groups for most of the anesthesia duration except
for the period 30–35 min (Fig. 3B). However, the per-
centage in HR started to decline in control group but
remained high in RIPC group during the remaining per-
iod of RIPC. At the end of the 50 min duration there was
a significant difference between the two groups. The data
for changes in the ratio between low and HF components
of HRV spectra (LF/HF ratio) using HRV analysis, repre-
sent a measure of balance of sympatho-vagal activity. Up
to 20 min of RIPC, there was no difference between LF/
HF ratios compared to control (Fig. 3C). However, at
30 min the ratio was higher for RIPC but this was not
sustained toward the end of RIPC protocol.
The effect of RIPC on cardiac metabolites
With exception of adenosine (P < 0.02), none of the cel-
lular metabolites measured in freshly excised hearts after
50 min of anesthesia with or without application of RIPC
showed significant difference. Furthermore, upon calculat-
ing markers of ischemic stress (Atkinson and Walton
1967; Imura et al. 2011; Gout et al. 2014) including phos-
phorylation potential and adenylate energy charge, RIPC
was found to have a significant effect (Fig. 4). RIPC was
associated with a lower phosphorylation potential (ATP/
ADP, ATP/AMP, GTP/GDP, and GTP/GMP) compared
to control (Fig. 4A). Furthermore, adenylate energy
charge, an index of the metabolic status and reflects the
ability of the cell to make energy-rich phosphates from
precursors was also found to be lower in RIPC group
compared to control (Fig. 4B). The energy charge was
calculated using the following equation: Energy
Charge = (0.5 ADP + ATP)/(AMP + ADP + ATP) (Gout
et al. 2014).
The effect of RIPC on blood flow in hind limbs
Inflating blood pressure cuff during RIPC induced a com-
plete block of the microcirculatory blood flow in the
ischemic right limb (cuffed). During reperfusion there
was a strong hyperemic (increased blood flow) response
in this limb. However, this intervention in the right limb
was associated with a sustained reduction in blood flow
in the uncuffed nonischemic left limb (Fig. 5B). Fig-
ure 5C shows the calculated blood flow ratio for left
limb/contralateral right limb. The ratio was ~1 in anes-
thetized control mice without RIPC. However, during
RIPC application (reperfusion phase) the ratio was signif-
icantly lower compared to control mice. This appeared to
be due to sustained drop in blood flow in the uncuffed
hind limb.
Discussion
Validation of a mouse model of RIPC and
protection against I/R
In this study we validated the use of mouse model of
RIPC using a nonvolatile anesthetic where four cycles of
I/R of hind limb resulted in significant cardioprotection
as measured by size of infarction, cardiac enzyme release
and developed tension (Fig. 2). Most RIPC studies use
volatile anesthetics, which are known to produce pharma-
cological preconditioning (Ross and Foex 1999; Crom-
heecke et al. 2006). Other anesthetics including
pentobarbital can affect plasma catecholamine which in
turn may affect heart rate and other parameters including
temperature and blood pressure (Baum et al. 1985). In
our study we used tribromoethanol which is known to
produce appropriate surgical anesthesia, with sufficient
skeletal muscle relaxation and only a moderate degree of
respiratory depression and has a good margin of safety
(Murray et al. 2000). Furthermore, tribromoethanol has
the most predictable and reproducible level of cardiac
suppression and maintenance of heart rate compared to
other anesthetics (Hart et al. 2001; Gao et al. 2011).
Table 1. Effect of RIPC on cardiac function during index
ischemia.
Control RIPC P-value
Time to stop
beating (min)
8.6  1.2 10.3  4.0 0.66
Time to start
rigor contracture
(min)
17  2.6 19.3  2.7 0.55
Time to reach
maximal diastolic
tension (min) after
onset of rigor
11.0  2.5 9.3  2.5 0.65
Maximum diastolic
tension (mg)
869  105 711  100 0.31
Data are presented as mean  SEM (n = 7–8 hearts/group). RIPC,
remote ischemic preconditioning.
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Intermittent limb ischemia reduces blood
flow in contralateral limb
During RIPC, the reduced blood flow in cuffed limb is
associated with reactive hyperemia on reperfusion
(Fig. 5A and B). However, blood flow in the uncuffed
contralateral limb decreases during RIPC cycles (Fig. 5B
and C). More importantly this vasoconstriction effect was
dependent on the number of RIPC cycles as the first cycle
had small effect while maximum effect appears following
Figure 3. The effect of remote ischemic preconditioning (RIPC) on heart rate and heart rate variability. (A) Changes in heart rate (left panel)
and in tension (right panel) prior to ischemia and during equilibration measured in vitro (n = 10 hearts control, n = 7 hearts RIPC group). (B)
Heart rate percentage change from baseline during RIPC protocol in vivo (n = 19 for control and n = 13 hearts for RIPC group). (C) Low-/high-
frequency power spectrum density ratio in RIPC and control group during each reperfusion cycle (10, 20, 30, 40, and 50 min). Data are
presented as mean  SEM (n = 6 hearts in each group). *P < 0.05 versus control.
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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the third cycle. Most RIPC studies in mice used three or
four cycles of 5 min ischemia and 5 min reperfusion
(Lim et al. 2010; Cai et al. 2012; Kalakech et al. 2013).
This interesting observation regarding flow in the
uncuffed limb, suggests a gradual accumulative effect pos-
sibly due to release of vasoconstrictive endogenous factors
during RIPC cycles. However, this observation does not
appear to extend to other tissues as the blood flow in the
tail was not altered (Fig. 5B). It is possible, however, that
control of tail blood flow is different from that in limb
flow and in view of the finding that the control/contribu-
tion of sympathetic-mediated vasoconstriction responses
in skeletal muscle is not fully elucidated (Thomas and
Segal 2004).
Several studies have suggested release of humoral fac-
tors from the remotely preconditioned organ during
RIPC which include adenosine, bradykinin, opioid,
angiotensin 1, calcitonin gene-related peptide, endo-
cannabinoids, apolipoprotein A-1, heat shock proteins,
NO (Tanaka et al. 1998; Tang et al. 1999; Schoemaker
and van Heijningen 2000; Xiao et al. 2001; Brzozowski
et al. 2004a; Dong et al. 2004; Hibert et al. 2013), stromal
cell-derived factor-1 (Davidson et al. 2013), and micro-
RNA-144 (Li et al. 2014). However, it is unlikely that fac-
tors involved in hyperemic response which include
adenosine, bradykinin, and NO (Smits et al. 1995; Costa
and Biaggioni 1998; Nyberg et al. 2010) are responsible
for the observed vasoconstriction in the uncuffed limb
(Fig. 5). One possible explanation for the vasoconstriction
of microcirculatory blood vessels is that the release of
local triggers in the preconditioned limb stimulate neural
pathway(s) which in turn influence other organs (e.g.,
limb and heart). This is supported by studies showing
limb ischemia induces norepinephrine release from the
Figure 4. The effect of remote ischemic preconditioning (RIPC) on computed markers of ischemic stress. (A) Phosphorylation potential in hearts
collected immediately after RIPC protocol. (B) Energy charge calculated using energy charge equation. Data are mean  SEM (n = 7 hearts
from each group). *P < 0.05, **P < 0.005.
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Figure 5. Blood flow ratio in hind limbs during remote ischemic preconditioning (RIPC) application. (A and B) Representative images showing
changes of blood flow (color intensity) in both hind limbs of anesthetized mice. Top panel shows the flow during ischemia and following
reperfusion (hyperemia). Lower left hand panel shows blood flow in anesthetized mouse overtime without application of RIPC. Lower right
hand panel shows the changes in blood flow in limb exposed to four cycles of RIPC and the corresponding changes in its contralateral limb
(white rectangles). (C) Changes in blood flow ratio expressed as left (uncuffed) limb over right in control mice or in mice exposed to RIPC
application. Data extrapolated from color intensity (see colored panels above) and shown as mean  SEM (n = 3 hearts for control and four for
RIPC). Comparison was made between control and RIPC values at similar time points. *P < 0.05 versus corresponding control values. $P < 0.05
versus Cycle 1 (10 min).
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heart due to a systemic stress reaction, suggesting that
this process involves adrenergic nerve termini of the heart
(Oxman et al. 1997). The activation of neural pathways
such as a1 and a2 adrenergic signaling pathways release
epinephrine which leads to vasoconstriction of smooth
muscle (Vatner et al. 1986). Moreover, a1-adrenergic
receptor has been implicated in the cardioprotection by
RIPC (Taliyan et al. 2010). Whether measuring blood
flow in our study is linked to changes in coronary circula-
tion is not presently known. Nonetheless, it has been sug-
gested that peripheral changes in skin blood flow can
reflect generalized microvascular function including that
of the coronary circulation (Khan et al. 2008).
In contrast to our study, a limited number of studies
have reported vasodilatory effect when monitoring blood
flow in selected remote organs (e.g., heart) during RIPC
(Shimizu et al. 2007; Enko et al. 2011). In one study,
RIPC application in conscious volunteers was found to
induce vasodilatation of the contralateral artery (right
brachial artery) (Enko et al. 2011) while in another, RIPC
application in anesthetized pigs was associated with coro-
nary vasodilation (Shimizu et al. 2007). These two studies
were fundamentally different from our model where the
volunteers were conscious and anesthetized pigs hearts
were controlled by pacing during monitoring of coronary
flow resistance (Shimizu et al. 2007).
It is evident from our data that intermittent limb ische-
mia triggers reduced blood flow in contralateral limb and
that this effect appears to be dependent on number of
cycles. The work suggests a possible role for neuronal
(e.g., sympathetic) involvement. However, evidence for
direct involvement of neural autonomic control can be
extrapolated from monitoring changes in heart rate and
HRV as discussed below.
RIPC increases heart rate ex vivo and in vivo
and alters HRV
During the characterization of this mouse RIPC model, we
found that spontaneously beating Langendorff-perfused
hearts show significantly higher heart rate (computed from
developed tension) compared to control hearts (Fig. 3A).
This was also confirmed in vivo where % change from
baseline was significantly different at the end of RIPC
(50 min) compared to control (Fig. 3B). The relatively
higher heart rate in isolated-perfused heart after RIPC
application could be triggered by different factors including
changes in pacemaker cells excitability and the presence of
neurotransmitter stores in the heart (Hoover et al. 2004;
Tan et al. 2006). A likely trigger for increased heart rate is
an activation of sympathetic activity. This is consistent with
earlier evidence showing norepinephrine release from the
heart following RIPC (Oxman et al. 1997) and evidence of
PKA activation as shown by the increased phosphorylation
of ryanodine receptor 2 (Abdul-Ghani et al. 2013). ß-
blockers have been shown to block cardioprotection
induced by spinal cord stimulation or peripheral surgical
trauma (Southerland et al. 2007; Jones et al. 2009; Heusch
et al. 2015). Finally very recent study suggests that cardio-
protection by RIPC may involve intrinsic cardiac ganglia
(Pickard et al. 2016).
Further evidence for the involvement of autonomic
control of heart rate during RIPC comes from spectral
analysis of HRV. HRV is widely used as a measure of
ANS activity to the heart (sympatho-vagal balance) (Roy
and Ghatak 2013). The ratio between low and HF com-
ponents of HRV spectra (LF/HF) ratio was relatively
higher after reperfusion in the third cycle in RIPC group
compared to control suggesting the involvement of sym-
pathetic activity (Milicevic 2005). This finding contrasts
with work showing intermittent human limb ischemia is
associated with increased parasympathetic activity (Enko
et al. 2011). This, however, was tested in conscious vol-
unteers with no evidence of cardioprotection. The find-
ing that RIPC is associated with increased in
sympathetic activity can be used to explain the increase
in heart rate and vasoconstriction in limb’s blood vessel.
Moreover, these activities would render the heart
metabolically stressed. To address this issue, the myocar-
dial energetics were monitored in control and in RIPC
hearts.
RIPC alters cardiac energetics
Unexpectedly, our study showed signs of mild ischemic
stress in RIPC hearts as evidenced by a relatively lower
myocardial ATP/ADP, ATP/AMP, GTP/GDP, and GTP/
GMP ratios and in energy charge (Fig. 4). Clearly the
extent of this anaerobic stress is relatively smaller than what
is seen following classical preconditioning where ATP levels
fall by as much as 30% (Murry et al. 1990). The impor-
tance/relevance of this mild stress is not presently known.
It is likely, however, that this change could trigger signaling
pathways involved in protecting the heart during RIPC.
Summary and Conclusions
RIPC is associated with changes in cardiac and distal car-
diovascular activities, consistent with ANS involvement
which would contribute to cardioprotection.
Clinical Perspective
Large amount of experimental data is available demon-
strating that RIPC is a powerful, simple, noninvasive car-
dioprotective intervention. However, thus far this
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intervention has failed to convincingly translate into clini-
cal practice. Lack of understanding of the signals mediat-
ing the response from distant organ to the heart or the
cardiovascular changes during the application of RIPC
and prior to index ischemia is likely to be key in hinder-
ing the translation of the RIPC intervention. Our work
provides evidence for significant cardiovascular changes
consistent with the involvement of ANS and myocardial
metabolic stress during RIPC application which would
provide an explanation for subsequent cardioprotective
effects. These findings should prompt new translational/
clinical studies that will take into account these changes
in order to optimize conditions to take advantage of this
intervention.
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